91
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

The diagnosis and management of tuberculosis in HIV-infected children

&
Pages 9-13 | Published online: 15 Jul 2015

References

  • Cotton MF, Schaaf HS, Hesseling AC, Madhi SA. HIV and childhood tuberculosis the - way forward. Int J Tuberc Lung Dis 2004; 8:675–682
  • Schaaf HS, Gie RP, Beyers N, Sirgel FA, De Klerk PJ, Donald PR. Primary drug-resistant tuberculosis in children. Int J Tuberc Lung Dis 2000; 4: 1149–1155
  • Kiwanuka J, Graham SM, Coulter JB, et al. Diagnosis of pulmonary tuberculosis in children in an HIV-1 endemic area, Malawi. Ann Trop Pediatr 2001; 21:5–14
  • Zar HJ, Hanslo D, Tannenbaum E, et al. Aetiology and outcome of pneumonia in human immunodeficiency virus-infected children hospitalized in South Africa. Acta Paediatr 2001; 90: 119–125
  • Madhi SA, Petersen K, Madhi A, Khoosal M, Klugman KP. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis 2000; 31:170–176
  • Jeena PM, Pillay P, Pillay T, Coovadia RM. Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa. Int J Tuberc LungDis 2002; 6:672–678
  • Madhi SA, Huebner RE, Doedens L, Aduc T, Wesley D, Cooper P. HIV co-infection in children hospitalised with tuberculosis in South Africa. Int J Tuberc LungDis 2000; 4:448–454
  • Topley JM, Bamber S, Coovadia HM, COff PD. Tuberculous meningitis and co-infection with HIV. Ann Trop Paediatr 1998; 18: 261–266
  • Pillay T, Sturm AW, Khan M, et al. Vertical transmission of Mycobacterium tuberculosis in KwaZulu Natal: impact of HIV-1 co-infection. Int J Tuberc LungDis 2004; 8:59–69
  • Hesseling AC, Werschlcul H, Westra A, et al. The clinical features and outcome of confirmed tuberculosis in HIV-infected children. Int J Tuberc LungDis 2002; 6( Suppl 1): S181
  • Schaaf HS, Geldenhuys A, Gie RP, Cotton MF. Culture-positive tuberculosis in human immunodeficiency virus type 1-infected children. Pediatr InfectDis J1998; 17:599–604
  • Mandalakas AM, Guay L, Musoke P, Carroll-Pankhurst C, Olness KN. Human immunodeficiency virus status and delayed-type hypersensitivity skin testing in Ugandan children. Pediatrics 1999; 103(2): E21
  • Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in SouthAfrican children with a T-cell-based assay: a prospective cohort study. Lancet 2004; 364:2196–2203
  • Jeena PM, Coovadia HIM, Thula SA, Blythe D, Buckels NJ, Chetty R. Persistent and chronic lung disease in HIV-1 infected and uninfected Afiican children. AIDS 1998; 12: 1185–1193
  • Hesseling AC, Schaaf HS, Gie RP, Starke JR, Beyers N. A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. Int J Tuberc LungDis 2002; 6: 1038–1045
  • Van Rheenen P. The use of the paediatric tuberculosis score chart in an HIV-endemic area. Trop Med Int Health 2002; 7:435–441
  • Department of Health. The South African Tuberculosis Control Programme practical guidelines 2000
  • Driver CR, Munsiff SS, Li J, Kundamal N, Osahan SS. Relapse in persons treated for drug-susceptible tuberculosis in a population with high co-infection with human immunodeficiency virus in New York City. Clin Infect Dis 2000; 33: 1762–1769
  • Espinal MA, Reingold AL, Perez G, et al. Human immunodeficiency virus infection in children with tuberculosis in Santo Domingo, Dominican Republic: prevalence, clinical fmdings, and response to antituberculosis treatment. J Acquir Immune Defic Syndr Hum Retroyirol1996; 13: 155–159
  • Jindani A, Nunn AJ, Enarson DA. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial. Lancet 2004; 364: 1244–1251
  • Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Unit, 1946-1986, with relevant subsequent publications. Int J Tuberc LungDis 1999; 3: S231–S279
  • Zachariah R, Spielmann MP, Chinji C, et al. Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi. AIDS 2003; 17(7): 1053–1061
  • Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 2002; 359:2059–2064
  • Burman WJ, Jones BE. Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy. Am J Respir Crit Care Med 2001; 164:7–12
  • Centers for Disease Control, and Prevention, National Center for HIV, STD, and TB Prevention, and Division Tuberculosis Elimination. Updated guidelines for the use of rifamycins for the treatment of tuberculosis in HIV-infected patients taking protease inhibitors or non-nucleoside reverse transcriptase inhibitors. www.cdc.govinchstp/tb/TB_HIV_Drugs/TOC.htm
  • Cohen K, Maartens G. Management of HIV and tuberculosis co-infection in SouthAfrica. SAfr J HIV Med 2004; May (Issue 15): 8–12
  • Schaaf HS, Parkin DP, Seifart HI, et al. Isoniazid pharmacokinetics in children treated for respiratory tuberculosis. Arch Dis Child 2005 (in press)
  • Sahai J, Gallicano K, Swick L, et al. Reduced plasma concentrations of antituberculous drugs in patients with HIV infection. Ann Intern Med 1997; 127: 289–293
  • Dean GL, Edwards SG, Ives NJ, et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. A/DS2002; 16:75–83
  • Shelburne SA 3rd, Hamill RJ. The immune reconstitution inflammatory syndrome. AIDS Rey 2003; 5:67–79
  • Wendel KA, Alwood KS, Gachuhi R, Chaisson RE, Bishai WR, Sterling TR. Paradoxical worsening of tuberculosis in HIV-infected persons. Chest 2001; 120: 193–197